Quinoxaline–Triazole Hybrids: Exploring the Impact of Substituent Architecture on Cytotoxic Potency and Receptor Interaction
Chemistry & Biodiversity · 2026-11 · 23 (11)
DOI: 10.1002/cbdv.71770 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 30.10.2026. Verfasst von Bangar Reddy Vancha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Yogi Vemana University, Kadapa, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Quinoxalines, Triazoles, Antineoplastic Agents, Receptor, Adenosine A1. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Anusandhan National Research Foundation (ANRF), New Delhi, India, the Sigrid Juselius Foundation and the CSC-IT Center for Science, the Agency for Innovative Development of the Republic of Uzbekistan.
Abstract (Originalsprache)
A series of quinoxaline–1,2,4‐triazole derivatives ( 6a – 6l ) was synthesized and characterized by NMR and mass spectrometry; yields reached 80% for the long‐chain alkyl members, which points to substituent architecture as the determining factor in synthetic efficiency. MTT assays against MCF‐7, HeLa, and HepG2 cells identified 6e and 6k as the most active compounds, with IC 50 values of 50.83–62.69 µg/mL across the three lines. Docking against the adenosine A1 receptor gave binding energies of −9.02 kcal/mol for 6e and −9.24 kcal/mol for 6k , driven by hydrophobic and π–π interactions with key binding‐site residues. Ligand–receptor complexes remained stable through 600 ns of molecular dynamics, and umbrella sampling estimated binding free energies of −129.46 and −88.46 kJ/mol, respectively. ADMET predictions indicated drug‐likeness and favorable gastrointestinal absorption. 6e and 6k are therefore taken forward as lead candidates for mechanistic, pharmacological and in vivo evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Yogi Vemana University, Kadapa, Andhra Pradesh, India.
- Coromandel Innovation Centre, Coromandel International Limited, Hyderabad, Telangana, India.
- Research and Development Department, Denisco Chemicals Pvt Ltd, Hyderabad, Telangana, India.
- Department of BMB, School of Allied Healthcare Sciences, Malla Reddy University, Hyderabad, Telangana, India.
- Institute of Bioorganic Chemistry of Uzbekistan Academy of Sciences, Tashkent, Uzbekistan.
- Laboratory of Experimental Biophysics, Centre for Advanced Technologies, Tashkent, Uzbekistan.
ORCID-Profile: Bangar Reddy Vancha, Shaik Farheen Banu, Satyanarayana Swamy Vyshnava, Mukhriddin Makhkamov, Jamoliddin Razzokov, Peddiahgari Vasu Govardhana Reddy
Förderung
- Anusandhan National Research Foundation (ANRF), New Delhi, India
- the Sigrid Juselius Foundation and the CSC-IT Center for Science
- the Agency for Innovative Development of the Republic of Uzbekistan
Zitieren
APA
Vancha, B. R., Sreeshitha, M., Banu, S. F., Vasikarla, K. P., Vyshnava, S. S., Makhkamov, M., Marimuthu, P., Razzokov, J., Islam, A., & Reddy, P. V. G. (2026). Quinoxaline–Triazole Hybrids: Exploring the Impact of Substituent Architecture on Cytotoxic Potency and Receptor Interaction. Chemistry & Biodiversity, 23(11). https://doi.org/10.1002/cbdv.71770
Vancouver
Vancha BR, Sreeshitha M, Banu SF, Vasikarla KP, Vyshnava SS, Makhkamov M, et al. Quinoxaline–Triazole Hybrids: Exploring the Impact of Substituent Architecture on Cytotoxic Potency and Receptor Interaction. Chemistry & Biodiversity. 2026;23(11). doi:10.1002/cbdv.71770
BibTeX
@article{Vancha2026,
author = {Vancha, Bangar Reddy and Sreeshitha, Mandapalli and Banu, Shaik Farheen and Vasikarla, Kamala Prasad and Vyshnava, Satyanarayana Swamy and Makhkamov, Mukhriddin and Marimuthu, Parthiban and Razzokov, Jamoliddin and Islam, Aminul and Reddy, Peddiahgari Vasu Govardhana},
title = {Quinoxaline–Triazole Hybrids: Exploring the Impact of Substituent Architecture on Cytotoxic Potency and Receptor Interaction},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {11},
doi = {10.1002/cbdv.71770}
}
EUVIMED